Research analysts at Cantor Fitzgerald decreased their FY2025 earnings per share estimates for Beam Therapeutics in a note issued to investors on Wednesday, February 26th. Cantor Fitzgerald analyst R.

Xometry (NASDAQ:XMTR – Free Report) had its target price upped by Cantor Fitzgerald from $12.00 to $20.00 in a research note issued to investors on Wednesday morning,Benzinga reports. The brokerage ...

We recently compiled a list of the 10 Best Stocks Under $50 to Buy Right Now. In this article, we are going to take a look at ...

Blackwell is still in its early days, but at $11 billion, it made up nearly a third of Nvidia's data-center revenue, Cantor Fitzgerald analyst C.J. Muse noted. (Nvidia's data-center business ...

Fintel reports that on February 26, 2025, Cantor Fitzgerald downgraded their outlook for Jazz Pharmaceuticals (NasdaqGS:JAZZ) ...

Today, Benzinga's options scanner spotted 8 options trades for Riot Platforms. This isn't normal. The overall sentiment of ...

The Central Bank said the firm failed to put effective arrangements in place to detect and report suspicious transactions.

In a report released today, Andres Sheppard from Cantor Fitzgerald maintained a Buy rating on Joby Aviation (JOBY – Research Report), with a ...

Cantor Fitzgerald analyst Andres Sheppard reiterated a Buy rating on Intuitive Machines (LUNR – Research Report) yesterday and set a price ...

In a notable holding, the Delaware Supreme Court has confirmed that forfeiture-for-competition provisions generally are not subject to ...

All Remote - GitLab Inc., (NASDAQ: GTLB), the most comprehensive AI-powered DevSecOps platform, today announced that GitLab Chief Financial Officer Brian Robins will present at the 2025 Cantor ...